Jane H. Hollingsworth - 13 May 2021 Form 4 Insider Report for Diffusion Pharmaceuticals Inc. (CRVO)

Role: Director
Signature: /s/ William R. Elder, attorney-in-fact for the Reporting Person
Issuer symbol: CRVO
Transactions as of: 13 May 2021
Net transactions value: +$19,999
Form type: 4
Filing time: 17 May 2021, 16:27:42 UTC
Next filing: 06 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DFFN	Common Stock	Purchase	$19,999	+32,786		$0.6100	32,786	13 May 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. The shares were purchased in multiple open-market transactions at prices ranging from $0.6097 to $0.6141, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares sold at each separate price within such range.

Content

The price reported is a weighted average price. The shares were purchased in multiple open-market transactions at prices ranging from $0.6097 to $0.6141, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares sold at each separate price within such range.